doi: 10.1016/j.neuropharm.2011.10.004 2 AgranoffB
Journal of Assisted Reproduction and Genetics , 37 , 14671476
36 Despa S , Islam MA , Weber CR , Pogwizd SM , Bers DM
NIACINAMIDE ESSENCE 3% Water, Niacinamide, Propanediol, Glycerin, Sodium Hyaluronate, Biosaccharide Gum-1, Beta-Glucan, Hydroxyacetophenone, Dipropylene Glycol, Phenoxyethanol, Xanthan Gum, Caprylyl Glycol, Acacia Senegal Gum, Algin, Benzoic Acid, Sorbic Acid, Sodium Hydroxide
FDA investigators found that drug products produced failed to meet the conditions of Section 503A of the FDCA, including that Foothills did not receive valid prescriptions for individually identified patients for a portion of the drug products produced, and that investigators noted serious deficiencies in drug production practices that put patients at risk